Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04910802 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04910802 · ClinicalTrials.gov record · last posted 2021-09-16

Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden

StatusRecruiting
PhasePhase 4
Started2021-05-03
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 16, 2021 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
The study aims to evaluate whether organised, concomitant HPV vaccination and HPV screening offered to all resident women aged 22-27 will result in a more rapid elimination of HPV infection in Sweden. This objective will be examined at the population level.

Amendment record 1 amendment on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended once since 2021-05-29. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

Trial Details
NCT Number NCT04910802
Lead Sponsor Miriam Elfström
Collaborators: Karolinska University Hospital
Conditions HPV Infection, CIN 2/3, Cervical Cancer
Enrollment 150,000 participants
Start Date 2021-05-03
Primary Completion 2025-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2021-09-16